Modulation of serine proteinases and metalloproteinases during morphogenic glial-endothelial interactions

Journal of Neurochemistry

Volumn 66, Issue 4, 1996, Pages 1657-1664

  Rao, Jasti S ^a,c   Sawaya, Raymond ^a   Gokaslan, Ziya L ^a   Yung, W K Alfred ^a   Goldstein, Gary W ^b   Laterra, John ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Collagenases; Fibrinolysis; Plasminogen activator inhibitors; Plasminogen activators

Indexed keywords

COLLAGENASE; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; SERINE PROTEINASE;

ANIMAL CELL; ARTICLE; CATTLE; CELL INTERACTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; FIBRINOLYSIS; GLIA CELL; NONHUMAN; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0029875280     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66041657.x     Document Type: Article

References (55)

1. Andreasen P. A., Georg B., Lund L. R., Riccio A., and Stacey S. N. (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol. 68, 1-19.
2. Ashton N. (1965) The blood-retinal barrier and vaso-glial relationships in retinal disease. Trans. Ophthalmol. Soc. UK 85, 199-205.
3. Ausprunk D. H. and Folkman J. (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. J. Microvasc. Res. 14, 53-65.
4. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. (1968) Differentiated rat glial cell stain in tissue culture. Science 161, 370-371.
5. Blasi F., Vassalli J. D., and Danø K. (1987) Urokinase type plasminogen activator, proenzyme, receptor, and inhibitors. J. Cell Biol. 104, 801-804.
6. Booth N. A., Bennett R., Wijngaards G., and Grieve J. H. K. (1983) A new life-long hemorrhagic disorder due to excess plasminogen activator. Blood 61, 267-275.
7. Bradford M. M. (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72, 859-864.
8. Broadwell R. D., Charlton H. M., Ebert P. S., Hickey W. F., Shirazi Y., Villegas J., and Wolf A. L. (1991) Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts. Exp. Neurol. 112, 1-28.
9. T 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50, 6184-6191.
10. Caley D. W. and Maxwell D. S. (1970) Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J. Comp. Neurol. 138, 31-48.
11. Cavanaugh K. P., Gurwitz D., Cunningham D. D., and Bradshaw R. (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54, 1735-1743.
12. Choi B. H., Suzuki M., Kim T., Wagner S. L., and Cunningham D. D. (1990) Protease nexin-1: localization in the human brain suggests a protective role against extravasated senne proteases. Am. J. Pathol. 137, 741-747.
13. Danø K., Andreasen P. A., Grondahl-Hansen J., Kristensen P., Nielsen L. S., and Skriver L. (1985) Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44, 139-266.
14. Desrochers P. E., Jeffrey J. J., and Weiss S. J. (1991) Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J. Clin. Invest. 87, 2258-2265.
15. Deutsch D. G. and Mertz E. T. (1970) Plasminogen purification from human plasma by affinity chromatography. Science 170, 1095-1096.
16. Ellis V., Behrendt N., and Dano K. (1991) Plasminogen activation by receptor-bound urokinase: a kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266, 12752-12758.
17. Festoff B. W., Rao J. S., Maben C., and Hantai D. (1990) Plasminogen activators and their inhibitors in neuromuscular system. I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines. J. Cell. Physiol. 144, 262-271.
18. Festoff B. W., Hantai D., and Rao J. S. (1991) Protease nexin I: a serpin fibrinolytic protease inhibitor and neurite outgrowth promoter localizes at neuromuscular synapses with acetylcholine receptors. J. Cell. Physiol. 147, 76-86.
19. Fisher C., Gilbertson-Beadling S., Powers E. A., Petzold G., Poorman R., and Mitchell M. A. (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 162, 499-510.
20. Gavrilovic J., Hembry R. M., Reynolds J. J., and Murphy G. (1987) Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J. Cell Sci. 87, 357-362.
21. Gross J. L., Moscatelli D., Jaffe E. A., and Rifkin D. B. (1982) Plasminogen activator and collagenase production by cultured capillary endothehal cells. J. Cell Biol. 95, 974-981.
22. Hasty K. A., Powrmotabled T. F., Goldberg G. I., Thompson J. P., Spinella D. G., Stevens R. M., and Mainardi C. L. (1990) Human neutrophil collagenase. J. Biol. Chem. 265, 11421-11424.
23. Herron G. S., Werb Z., Dwyer K., and Banda M. J. (1986a) Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261, 2810-2813.
24. Herron G. S., Banda M. J., Clark E. J., Gavrilovic J., and Werb Z. (1986b) Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem. 261, 2814-2818.
25. Ingber D. E. and Folkman J. (1989) Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro. J. Cell Biol. 109, 317-330.
26. Kubota Y., Kleinman H. K., Martin G. R., and Lawley T. J. (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 197, 1589-1598.
27. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
28. Lane T. F., Iruela-Arispe M. L., and Sage E. H. (1992) Regulation of gene expression by SPARC during angiogenesis in vitro. J. Biol. Chem. 267, 16736-16745.
29. Laterra J. and Goldstein G. W. (1991) Astroglial-induced in vitro angiogenesis: requirements for RNA and protein synthesis. J. Neurochem. 57, 1231-1239.
30. Laterra J., Guerin C., and Goldstein G. W. (1990) Astrocytes induce neural microvascular endothelial cells to form capillary-like structures in vitro J. Cell. Physiol. 144, 204-215.
31. Laterra J., Indurti R. R., and Goldstein G. W. (1994) Regulation of in vitro glia-induced microvessel morphogenesis by urokinase. J. Cell. Physiol. 158, 317-324.
32. Ling T. and Stone J. (1988) The development of astrocytes in the cat retina: evidence of migration from the optic nerve. Dev. Brain Res. 44, 73-85.
33. Liotta L. A., Lee C. W., and Morakis D. J. (1980) New method for preparing large surfaces of intact human basement membrane for tumor invasion studies. Cancer Lett. 11, 141-152.
34. Mignatti P., Tsuboi R., Robbins E., and Rifkin D. B. (1989) In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108, 671-682.
35. Minakawa T., Bready J., Berliner J., Fisher M., and Cancilla P. A. (1991) In vitro interaction of astrocytes and pericytes with capillary-like structures of brain microvessel endothelium. Lab. Invest. 65, 32-40.
36. Monard D., Niday E., Limat A., and Solomon F. (1983) Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog. Brain Res. 58, 359-364.
37. Moscatelli D. and Rifkin D. B. (1988) Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta 948, 67-85.
38. Moscatelli D., Jaffe E., and Rifkin D. B. (1980) Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell 20, 343-351.
39. Moscatelli D., Presta M., and Rifkin D. B. (1986) Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc. Natl. Acad. Sci. USA 83, 2091-2095.
40. Nakajima M., Lotan D., Baig M., Carralero R M., Wood W. R., Hendrix M. J. C., and Lotan R. (1989) Inhibition of retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 49, 1698-1706.
41. Ossowski L., Biegel D., and Reich E. (1979) Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16, 929-940.
42. 1 on in vitro angiogenesis. Exp. Cell Res. 204, 356-363.
43. Rabbani S. A., Mazar A. P., Bernier S. M., Ilaq M., Bolivar I., Henkin J., and Goltzman D. (1992) Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267, 14151-14156.
44. Rao J. S., Baker J. B., Morantz R. A., Kimler B., Evans R., and Festoff B. W. (1990) Serpin inhibitors of urokinase and thrombin in normal rat brain and 9L brain tumor: elevated expression of PNI-like inhibitor in a gliosarcoma in vivo and in vitro. Cancer Res. 50, 5039-5044.
45. Rao J. S., Cheng M., Steck P. A., Mohaman S., Stetler-Stevenson W. G., Liotta L. A., and Sawaya R. (1993) Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53, 2208-2211.
46. Rubin L. L., Hall D. E., Porter S., Barbu K., Cannon C., Horner H. C., Janatpour M., Liaw C. W., Manning K , Morales J., Tanner L. I., Tomaselli K. J., and Bard F. (1991) A cell culture model of the blood-brain barrier. J. Cell Biol. 115, 1725-1735.
47. Saksela O. and Rifkin D. B. (1988) Cell-associated plasminogen activation: regulation and physiologic functions. Annu. Rev. Cell Biol. 4, 93-126.
48. Saksela O., Moscatelli D., and Rifkin D. B. (1987) The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol. 105, 957-964.
49. Sawaya R. and Highsmith R. (1988) Plasminogen activator activity and molecular weight patterns in human brain tumors. J. Neurosurg. 68, 72-79.
50. Stetler-Stevenson W. G., Krutzsch H. C., Wacher M. P., Margulies I. M. K., and Liotta L. A. (1989) The activation of human type IV collagenase proenzyme. J. Biol. Chem. 264, 17374-17378.
51. Strickland S., Reich F., and Sherman M. I. (1976) Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 9, 231-240.
52. Tao-Cheng J.-H., Nagy Z., and Brightman M. W. (1987) Tight junctions of brain endothelium in vitro are enhanced by astroglia. J. Neurosci. 7, 3293-3299.
53. Vallee B. L. and Auld D. S. (1990) Zinc coordination, function and structure of zinc enzymes and other proteins. Biochemistry 29, 5647-5659.
54. Vassalli J. D. and Belin D. (1987) Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 214, 187-191.
55. Wolff J. E. A., Laterra J., and Goldstein G. W. (1992) Steroid inhibition of neural microvessel morphogenesis in vitro: receptor mediation and astroglial dependence. J. Neurochem. 58, 1023-1032.